Jeffrey B. Landau - Chief Business Officer at CytomX Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Issuer Symbol
CTMX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jeffrey B. Landau since 11 Mar 2025

Holdings reported by Jeffrey B. Landau for CytomX Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 119,056 $146,332 $1.23 20 Aug 2024 Direct
Common Stock 4,500 $5,531 $1.23 20 Aug 2024 Fidelity Traditional IRA
Common Stock 3,180 $3,909 $1.23 20 Aug 2024 Schwab ROTH IRA
Performance Stock Units (PSUs) 0 $0 $1.23 20 Aug 2024 Direct Common Stock
Stock Option (Right to Buy) 140,000 18 Jan 2024 Direct Common Stock

Transactions reported by Jeffrey B. Landau for CytomX Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.